Is Caring Brands, Inc. Common Stock (CABR) overvalued? · rev $4.2K
Caring Brands, Inc. Common Stock (CABR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
This page asks whether Caring Brands, Inc. Common Stock (CABR) looks expensive on cached numbers — not a short thesis.
Latest reported CABR revenue for 2025-12-31 was $4.2K. Net income was -$6.3M. Revenue was up 806.5% from 2024-12-31 to 2025-12-31. CABR currently screens at market cap $10.9M.
CABR currently screens at market cap $10.9M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next CABR 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the CABR stock page for the full model, not this heading.
Not investment advice.